+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Epinephrine Autoinjector Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report
  • 100 Pages
  • July 2022
  • Region: Global
  • Infinium Global Research
  • ID: 5642833
UP TO OFF until Dec 31st 2022
The report on the global epinephrine autoinjector market provides qualitative and quantitative analysis for the period from 2022 to 2028. The report predicts the global epinephrine autoinjector market to grow with a CAGR of nearly 8% over the forecast period from 2022-2028. The study on epinephrine autoinjector market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.

The report on epinephrine autoinjector market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global epinephrine autoinjector market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global epinephrine autoinjector market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rising prevalence of anaphylaxis that occurs in cardiac arrest, allergy, and asthma will propel the growth of the market.
  • The increasing geriatric population will fuel the market growth.

2) Restraints

  • The high cost of epinephrine autoinjectors is expected to restrain the market growth during the forecast period.

3) Opportunities

  • Development of automatic injection devices to further create growth opportunities for the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global epinephrine autoinjector market is segmented on the basis of dosage, and end-user.

The Global Epinephrine Autoinjector Market by Dosage

  • 0.15 Mg Epinephrine Autoinjector
  • 0.3 Mg Epinephrine Autoinjector
  • 0.5 Mg Epinephrine Autoinjector

The Global Epinephrine Autoinjector Market by End-User

  • Hospital
  • Clinics
  • Individual

Company Profiles

The companies covered in the report include
  • Pfizer Inc.
  • Mylan Inc.
  • ALK Abello
  • Sanofi SA
  • Lincoln Medical Ltd
  • Teva Pharmaceuticals Ltd
  • Antares Pharma Inc.
  • Hospira Inc.
  • Impax Laboratories, Inc.
  • Bausch & Lomb Incorporated

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the epinephrine autoinjector market.
2. Complete coverage of all the segments in the epinephrine autoinjector market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global epinephrine autoinjector market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Epinephrine Autoinjector Market Highlights
2.2. Epinephrine Autoinjector Market Projection
2.3. Epinephrine Autoinjector Market Regional Highlights
3. Global Epinephrine Autoinjector Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Epinephrine Autoinjector Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Dosage
3.5.2. Growth Matrix Analysis by End-User
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Epinephrine Autoinjector Market
4. Epinephrine Autoinjector Market Macro Indicator Analysis
5. Global Epinephrine Autoinjector Market by Dosage
5.1. 0.15 Mg Epinephrine Autoinjector
5.2. 0.3 Mg Epinephrine Autoinjector
5.3. 0.5 Mg Epinephrine Autoinjector
6. Global Epinephrine Autoinjector Market by End-User
6.1. Hospital
6.2. Clinics
6.3. Individual
7. Global Epinephrine Autoinjector Market by Region 2022-2028
7.1. North America
7.1.1. North America Epinephrine Autoinjector Market by Dosage
7.1.2. North America Epinephrine Autoinjector Market by End-User
7.1.3. North America Epinephrine Autoinjector Market by Country
7.2. Europe
7.2.1. Europe Epinephrine Autoinjector Market by Dosage
7.2.2. Europe Epinephrine Autoinjector Market by End-User
7.2.3. Europe Epinephrine Autoinjector Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Epinephrine Autoinjector Market by Dosage
7.3.2. Asia-Pacific Epinephrine Autoinjector Market by End-User
7.3.3. Asia-Pacific Epinephrine Autoinjector Market by Country
7.4. RoW
7.4.1. RoW Epinephrine Autoinjector Market by Dosage
7.4.2. RoW Epinephrine Autoinjector Market by End-User
7.4.3. RoW Epinephrine Autoinjector Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Epinephrine Autoinjector Market
8.2. Companies Profiled
8.2.1. Pfizer Inc.
8.2.2. Mylan Inc.
8.2.3. ALK Abello
8.2.4. Sanofi SA
8.2.5. Lincoln Medical Ltd
8.2.6. Teva Pharmaceuticals Ltd
8.2.7. Antares Pharma Inc.
8.2.8. Hospira Inc.
8.2.9. Impax Laboratories, Inc.
8.2.10. Bausch & Lomb Incorporated

Companies Mentioned

  • Pfizer Inc.
  • Mylan Inc.
  • ALK Abello
  • Sanofi SA
  • Lincoln Medical Ltd
  • Teva Pharmaceuticals Ltd
  • Antares Pharma Inc.
  • Hospira Inc.
  • Impax Laboratories, Inc.
  • Bausch & Lomb Incorporated